Profilo
Rosalind Wilson is currently Chief Medical Officer at Prescient Therapeutics Ltd. since 2026.
Former roles include Chief Executive Officer at Invert Graphite Ltd. from 2017 to 2019 and Non-Executive Director at AdAlta Ltd. from 2019 to 2020.
Education includes a doctorate from Monash University and an MBA from London Business School.
Posizioni attive di Rosalind Wilson
| Società | Posizione | Inizio |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Direttore Tecnico/Scientifico/R&S | 13/07/2026 |
Precedenti posizioni note di Rosalind Wilson
| Società | Posizione | Fine |
|---|---|---|
| ADALTA LIMITED | Direttore/Membro del Consiglio | 27/03/2020 |
| INVERT GRAPHITE LIMITED | Amministratore Delegato | 25/01/2019 |
Formazione di Rosalind Wilson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Invert Graphite Ltd.
Invert Graphite Ltd. Construction MaterialsNon-Energy Minerals Engages in mining of lime and other minerals | Non-Energy Minerals |
Prescient Therapeutics Ltd.
Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
















